If you’re anything like me, your pet’s comfort is of the utmost importance. A recent Phys.org article noted the FDA’s approval of the first monoclonal antibody treatment for feline arthritis. The drug is called Solensia, aka frunevetmab, and it’s a cat-specific monoclonal antibody that binds to a protein associated with pain, blocking the signal from reaching the brain. Solensia is marketed by Zoetis, and is only available via prescriptions from licensed veterinarians.
FDA Approves Osteoarthritis Pain Treatment for Cats
The prescription-only injection blocks pain signals from reaching the brain in cats.
Jan 17, 2022
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!Unlock Learning Here
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!Take Quiz